Indeed, we identified that DHEA and NALA were able to kill HNSCC cells through 5-LO-mediated ROS production in a receptor-independent manner, even though HNSCC cells might have expression of their receptors such as CB1 and/or VR1. The gene discussed is CNR1; the disease is head and neck squamous cell carcinoma.